104 related articles for article (PubMed ID: 19631515)
1. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; Frisina N; Mazzaferro S; Frisina A; D'Anna R; Cancellieri F; Cannata ML; Corrado F; Lubrano C; Marini R; Adamo EB; Squadrito F
Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):332-40. PubMed ID: 19631515
[TBL] [Abstract][Full Text] [Related]
2. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.
Atteritano M; Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Mazzaferro S; D'Anna R; Cannata ML; Gaudio A; Frisina A; Frisina N; Corrado F; Cancellieri F; Lubrano C; Bonaiuto M; Adamo EB; Squadrito F
J Clin Endocrinol Metab; 2007 Aug; 92(8):3068-75. PubMed ID: 17682090
[TBL] [Abstract][Full Text] [Related]
3. OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration.
Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Atteritano M; Gaudio A; Mazzaferro S; Frisina A; Frisina N; Lubrano C; Bonaiuto M; D'Anna R; Cannata ML; Corrado F; Cancellieri F; Faraci M; Marini R; Adamo EB; Wilson S; Squadrito F
J Bone Miner Res; 2008 May; 23(5):715-20. PubMed ID: 18433304
[TBL] [Abstract][Full Text] [Related]
4. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study.
Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; D'Anna R; Frisina N; Mazzaferro S; Cancellieri F; Cannata ML; Corrado F; Frisina A; Adamo V; Lubrano C; Sansotta C; Marini R; Adamo EB; Squadrito F
J Clin Endocrinol Metab; 2008 Dec; 93(12):4787-96. PubMed ID: 18796517
[TBL] [Abstract][Full Text] [Related]
5. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
6. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen.
Massé PG; Tranchant CC; Jougleux JL; Coburn SP; Cole DE
J Hum Nutr Diet; 2008 Apr; 21(2):117-28. PubMed ID: 18339052
[TBL] [Abstract][Full Text] [Related]
8. The hypoglycemic effects of soy isoflavones on postmenopausal women.
Cheng SY; Shaw NS; Tsai KS; Chen CY
J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
[TBL] [Abstract][Full Text] [Related]
9. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
[TBL] [Abstract][Full Text] [Related]
10. HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women.
Vogelvang TE; Mijatovic V; Kenemans P; Teerlink T; van der Mooren MJ
Fertil Steril; 2004 Dec; 82(6):1540-9. PubMed ID: 15589857
[TBL] [Abstract][Full Text] [Related]
11. Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial.
Bitto A; Polito F; Atteritano M; Altavilla D; Mazzaferro S; Marini H; Adamo EB; D'Anna R; Granese R; Corrado F; Russo S; Minutoli L; Squadrito F
J Clin Endocrinol Metab; 2010 Jun; 95(6):3067-72. PubMed ID: 20357174
[TBL] [Abstract][Full Text] [Related]
12. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
[TBL] [Abstract][Full Text] [Related]
14. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria.
Glew RH; Conn CA; Vanderjagt TA; Calvin CD; Obadofin MO; Crossey M; Vanderjagt DJ
J Health Popul Nutr; 2004 Dec; 22(4):357-69. PubMed ID: 15663169
[TBL] [Abstract][Full Text] [Related]
16. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome.
Bitto A; Altavilla D; Bonaiuto A; Polito F; Minutoli L; Di Stefano V; Giuliani D; Guarini S; Arcoraci V; Squadrito F
J Endocrinol; 2009 Mar; 200(3):367-76. PubMed ID: 19066292
[TBL] [Abstract][Full Text] [Related]
17. Genistein in the metabolic syndrome: results of a randomized clinical trial.
Squadrito F; Marini H; Bitto A; Altavilla D; Polito F; Adamo EB; D'Anna R; Arcoraci V; Burnett BP; Minutoli L; Di Benedetto A; Di Vieste G; Cucinotta D; de Gregorio C; Russo S; Corrado F; Saitta A; Irace C; Corrao S; Licata G
J Clin Endocrinol Metab; 2013 Aug; 98(8):3366-74. PubMed ID: 23824420
[TBL] [Abstract][Full Text] [Related]
18. Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
[TBL] [Abstract][Full Text] [Related]
19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
20. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
